معرفی
Edward C Cooper, M.D., Ph.D., is an Associate Professor in the Departments of Neurology, Neuroscience, and Molecular & Human Genetics at Baylor College of Medicine. His research focuses on understanding ion channel dysfunction in epilepsy and psychiatric disorders, particularly the role of KCNQ2/3 potassium channels in axonal excitability. He leads a multidisciplinary lab investigating genetic mechanisms of epilepsy, including KCNQ2 encephalopathy and ANK3-related psychiatric conditions. Dr. Cooper’s work integrates molecular, electrophysiological, and computational approaches, with translational goals to develop therapies for channelopathies.
Education: PhD in Cellular and Molecular Physiology (Yale University, 1991), MD (Yale University, 1990), Neurology residency at UCSF (1994), and postdoctoral training at UC San Francisco (2002).
Research Interests: Voltage-gated sodium/potassium channels in epilepsy, KCNQ2/3 channelopathies, ANK3’s role in psychiatric disorders, axonal ion channel targeting, and molecular evolution of ion channel systems. Key projects include the KCNQ2/3 case registry and variant curation efforts.
Lab & Funding: The Cooper Lab is supported by NINDS, CURE Epilepsy, and the American Epilepsy Society. Collaborations span basic science, clinical research, and translational medicine, with a focus on developing treatments for channelopathy-related conditions.
